Boro Dropulic
Plus aucun poste en cours
Profil
Boro Dropulic was the founder of VIRxSYS Corp.
(founded in 1998) and Opus Bio, Inc. (founded in 2004), where he held the title of Chief Science Officer & General Manager.
He also worked as an Advisor at GBP Capital.
Dr. Dropulic's education includes an MBA from The Johns Hopkins University, and undergraduate and doctorate degrees from The University of Western Australia.
Anciens postes connus de Boro Dropulic
| Sociétés | Poste | Fin |
|---|---|---|
Opus Bio, Inc.
 Opus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Opus Bio, Inc. develops and manufactures lentiviral gene delivery technologies. Its Lentiviral vectors (LV), technology platform is used for delivery of genetic sequence information into cells to reprogram function and to treat epithelial cancers. The company was founded by Boro Dropulic in 2004 and is headquartered in Baltimore, MD. | Fondateur | - |
VIRxSYS Corp.
 VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Fondateur | - |
GBP Capital
 GBP Capital Investment ManagersFinance Founded in 2005, GBP Capital is a venture capital firm located in Greenwich, Connecticut. | Private Equity Investor | - |
Formation de Boro Dropulic
| The Johns Hopkins University | Masters Business Admin |
| The University of Western Australia | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
GBP Capital
GBP Capital Investment ManagersFinance Founded in 2005, GBP Capital is a venture capital firm located in Greenwich, Connecticut. | Finance |
Opus Bio, Inc.
Opus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Opus Bio, Inc. develops and manufactures lentiviral gene delivery technologies. Its Lentiviral vectors (LV), technology platform is used for delivery of genetic sequence information into cells to reprogram function and to treat epithelial cancers. The company was founded by Boro Dropulic in 2004 and is headquartered in Baltimore, MD. | Commercial Services |
VIRxSYS Corp.
VIRxSYS Corp. BiotechnologyHealth Technology VIRxSYS Corp. is a holding company, which uses its proprietary platform technologies to develop therapies for serious human diseases. Its platform technologies include lentiviral vectors as a delivery vehicle for genes against certain diseases and for vaccine therapies. Its therapies are in various stages of development from pre-clinical through Phase II clinical trials. The company was founded by Boro Dropulic, William J. Turner, and Wiliam N. Sick Jr in 1998 and is headquartered in Gaithersburg, MD. | Health Technology |
